Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
0.932
-0.025 (-2.58%)
At close: Feb 21, 2025, 4:00 PM
0.940
+0.008 (0.85%)
After-hours: Feb 21, 2025, 7:21 PM EST
Nektar Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Nektar Therapeutics stock have an average target of 4.50, with a low estimate of 1.00 and a high estimate of 7.00. The average target predicts an increase of 382.73% from the current stock price of 0.93.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 13, 2025.
Analyst Ratings
The average analyst rating for Nektar Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 3 | 3 |
| Buy | 1 | 1 | 2 | 2 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6.5 | Strong Buy | Reiterates | $6.5 | +597.28% | Jan 13, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +329.09% | Jan 8, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $7 | Buy | Initiates | $7 | +650.91% | Nov 4, 2024 |
| BTIG | BTIG | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +329.09% | Sep 30, 2024 |
| Jefferies | Jefferies | Hold Maintains $0.5 → $1 | Hold | Maintains | $0.5 → $1 | +7.27% | Mar 6, 2024 |
Financial Forecast
Revenue This Year
101.07M
from 90.12M
Increased by 12.15%
Revenue Next Year
86.95M
from 101.07M
Decreased by -13.98%
EPS This Year
-0.78
from -1.45
EPS Next Year
-0.82
from -0.78
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 143.8M | 136.6M | 135.1M | |||
| Avg | 101.1M | 86.9M | 86.3M | |||
| Low | 85.1M | 61.2M | 55.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 59.5% | 35.2% | 55.4% | |||
| Avg | 12.1% | -14.0% | -0.7% | |||
| Low | -5.6% | -39.5% | -35.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.61 | -0.68 | -0.42 | ||
| Avg | -0.78 | -0.82 | -0.75 | ||
| Low | -0.81 | -0.96 | -0.91 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.